The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cellsevidence of different mechanisms of action

European Journal of Cancer

Volumn 36, Issue 5, 2000, Pages 664-674

  Smith, M L ^a   Hawcroft, G ^a   Hull, M A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Apoptosis; Colorectal cancer; Cyclooxygenase; Non steroidal anti inflammatory drug; Catenin

Indexed keywords

ACETYLSALICYLIC ACID; BETA CATENIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL LINE; COLORECTAL CANCER; CONTROLLED STUDY; DNA CONTENT; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; ASPIRIN; BETA CATENIN; CELL DIVISION; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; IMMUNOBLOTTING; INDOMETHACIN; ISOENZYMES; MEMBRANE PROTEINS; NITROBENZENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0034057928     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00333-0     Document Type: Article

References (39)

1. Levy G.N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J. 11:1997;234-247.
2. Elder D.J.E., Paraskeva C. NSAIDs to prevent colorectal cancer. a question of sensitivity Gastroenterology. 113:1997;1999-2003.
3. Luong C., Miller A., Barnett J., Chow J., Ramesha C., Browner M.F. Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nature Struct. Biol. 3:1996;927-933.
4. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA. 90:1994;11693-11697.
5. Kawamori T., Rao C.V., Siebert K., Reddy B.S. Chemopreventative activity of celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis. Cancer Res. 58:1998;409-412.
6. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
7. Min/+ mouse model. implications for prophylaxis and treatment of colon cancer Cancer Res. 57:1997;4316-4324.
8. Piazza G.A., Alberts D.S., Hixson L.J.et al. Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels. Cancer Res. 57:1997;2909-2915.
9. Elder D.J.E., Hague A., Hicks D.J., Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines. enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma cell lines Cancer Res. 56:1996;2273-2276.
10. Elder D.J.E., Halton D.E., Hague A., Paraskeva C. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective non-steroidal anti-inflammatory drug. independence from COX-2 protein expression Clin. Cancer Res. 3:1997;1679-1683.
11. Hanif R., Pittas A., Feng Y.et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52:1996;237-245.
12. Sheng H., Shao J., Kirkland S.C.et al. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 99:1997;2254-2259.
13. Shiff S.J., Qiao L., Tsai L.-L., Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96:1995;491-503.
14. Shiff S.J., Koutsos M.I., Qiao L., Rigas B. Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells. effects on cell cycle and apoptosis Exp. Cell Res. 222:1996;179-188.
15. Murphy V.J., Yang Z., Rorison K.A., Baldwin G.S. Cyclooxygenase-2-selective antagonists do not inhibit growth of colorectal carcinoma cell lines. Cancer Lett. 122:1998;25-30.
16. Hara A., Yoshimi N., Niwa M., Ino N., Mori H. Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn. J. Cancer Res. 88:1997;600-604.
17. He T.-C., Sparks A.B., Rago C.et al. Identification of c-MYC as a target of the APC pathway. Science. 281:1998;1509-1512.
18. Tetsu O., McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:1999;422-426.
19. Lesuffleur T., Kornowski A., Luccioni C.et al. Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation. Int. J. Cancer. 49:1991;721-730.
20. Leibowitz A., Stinson J.C., McCombs III W.B., McCoy C.E., Mazur K.C., Mabry N.D. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36:1976;4562-4569.
21. Futaki N., Takahashi S., Yokoyama M., Arai I., Higuchi S., Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins. 47:1994;55-59.
22. Hull M.A., Thomson J.L., Hawkey C.J. Expression of cyclooxygenase-1 and -2 by human gastric endothelial cells. Gut. 45:1999;529-536.
23. Johnson K.R., Lewis J.E., Li D.et al. P- and E-cadherin are in separate complexes in cells expressing both cadherins. Exp. Cell Res. 207:1993;252-260.
24. Hague A., Manning A.M., Hanlon K.A., Huschtscha L.I., Hart D., Paraskeva C. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway. implications for the possible role of dietary fibre in the prevention of large-bowel cancer Int. J. Cancer. 55:1993;498-505.
25. Parker J., Kaplon M.K., Alvarez C.J., Krishnaswamy G. Prostaglandin H synthase expression is variable in human colorectal adenocarcinoma cell lines. Exp. Cell Res. 236:1997;321-329.
26. Zhang X., Morham S.G., Langenbach R., Young D.A. Malignant transformation and anti-neoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J. Exp. Med. 190:1999;451-459.
27. Goldman A.P., Williams C.S., Sheng H.et al. Meloxicam inhibits the growth of colorectal cancer cells. Carcinogenesis. 19:1998;2195-2199.
28. Eberhart C.E., Coffey R.J., Radhika A., Giardello F.M., Ferrenbach S., DuBois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 107:1994;1183-1188.
29. Chapple KS, Cartwright EJ, Hawcroft G, et al. Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol 2000, in press.
30. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:1997;3406-3410.
31. Brockman J.A., Gupta R.A., DuBois R.N. Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology. 115:1998;1049-1055.
32. Qiao L., Hanif R., Sphicas E., Shiff S.J., Rigas B. Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cells. Biochem. Pharmacol. 55:1998;53-64.
33. Ilyas M., Tomlinson I.P.M., Rowan A., Pignatelli M., Bodmer W.F. β-catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. USA. 94:1997;10330-10334.
34. Kelloff J., Maltzman T., Piazza G., Ahnen D. NSAIDs may reactivate the adenomatous polyposis coli (APC) pathway to apoptosis. Gastroenterology. 114:1998;A620.
35. McEntee M.F., Chiu C.-H., Whelan J. Relationship of β-catenin and Bcl-2 expression to sulindac-induced regression of intestinal tumors in Min mice. Carcinogenesis. 20:1999;635-640.
36. Efstathiou J.A., Noda M., Rowan A.et al. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc. Natl. Acad. Sci. USA. 95:1998;3122-3127.
37. Schmeiser K., Grand R.J.A. The fate of E- and P-cadherin during the early stages of apoptosis. Cell Death Differentiation. 6:1999;377-386.
38. Orsulic S., Huber O., Aberle H., Arnold S., Kemler R. E-cadherin binding prevents β-catenin nuclear localization and b-catenin/LEF-1-mediated transactivation. J. Cell Sci. 112:1999;1237-1245.
39. Schmeiser K., Hammond E.M., Roberts S., Grand R.J.A. Specific cleavage of γ catenin by caspases during apoptosis. FEBS Lett. 433:1998;51-57.